FZD, Human (Vantictumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-FZD, Human (Vantictumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | FZD, Human (Vantictumab biosimilar) |
| Clone | Vantictumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG2 lambda |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | Inhib, FCM |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human FZD Recombinant Antibody. Vantictumab /vaen t kt maeb/ is a human IgG2 monoclonal antibody designed for the treatment of cancer. This drug was developed by OncoMed Pharmaceuticals Inc. in partnership with Bayer. OncoMed was awarded a patent in 2016, which is set to expire in 2029.[3] In April 2017, Bayer terminated its option to license vantictumab. |
| Immunogen | n/a |
| Other Names | Anti-FZD Recombinant Antibody, Research Grade Vantictumab, Anti-Human FZD Recombinant Antibody, OMP-18R5, Antibody Drug Analogues, Monoclonal Antibody, YR1315, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1345009-45-1 |
| Catalog # | YR1315 |
| Price | please inquire |
| Order / More Info | FZD, Human (Vantictumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies